GM23681
LCL from B-Lymphocyte
Description:
ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD1
COLLAGEN, TYPE VI, ALPHA-2; COL6A2
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Country of Origin
|
USA
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
COL6A2 |
Chromosomal Location |
21q22.3 |
Allelic Variant 1 |
G301S; ULLRICH CONGENITAL MUSCULAR DYSTROPHY |
Identified Mutation |
GLY301SER |
|
Gene |
COL6A2 |
Chromosomal Location |
21q22.3 |
Allelic Variant 2 |
P518S; ULLRICH CONGENITAL MUSCULAR DYSTROPHY |
Identified Mutation |
PRO518SER |
Remarks |
Clinically affected; walked at 14 months; holds head up, turns in bed, sits, stands, and walks (indoors and out) without assistance; can climb stairs with a handrail; unable to rise from floor at age 15 years old; generalized weakness (proximal > distal); toriticollis; undescended testes (orchiplexy); Goldenhaur syndrome; contractures (finger flexors, elbows, hips, knees, ankles); distal laxity in fingers; hyperkeratosis pilaris; restrictive lung disease; cardiac assessment notes narrow pulmonary valve treated in past with balloon stenting; creatine phosphokinase = 550; muscle biopsy noted to have dystrophic appearance; MRI of muscle showed diffuse fatty infiltration in the gluteal region; donor subject is a compound heterozygote: one allele has a G>A transition at nucleotide 901 in exon 8 of the COL6A2 gene (901G>A) resulting in a substitution of serine for glycine at codon 301 [Gly301Ser (G301S)]; and the second allele has a C>T transition at nucleotide 1552 in exon 19 (1552C>T) resulting in the substitution of serine for proline at codon 518 [Pro518Ser (P518S)]. |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|